The Cannabis Sector Is Ready for an Implosion: 1,500% Acquisition Premiums Make No Sense

Why Aphria Inc. (TSX:APH) agreeing to buy Broken Coast Cannabis Inc. for $230 million is a valuation exercise which needs to be completed in some alternative dimension where fundamentals do not matter.

With most Canadian cannabis producers now swimming in a sea of “funny money,” some funny math has taken over in the acquisition metrics used by firms such as Aphria Inc. (TSX:APH) in agreeing to buy Broken Coast Cannabis Inc. for $230 million on earlier this week, as covered by fellow Fool contributor Joseph Solitro.

While Mr. Solitro appears to be very bullish on the long-term prospects of Aphria following the announcement of this acquisition as well as a couple of other recent strategic moves made by Aphria, looking at the multiple paid for Broken Coast, I’m surprised the stock didn’t tank the minute the acquisition was announced.

According to Chris Damas of BCMI Research (one of the most reputable sources on the industry and the metrics behind the cannabis sector), Aphria has valued Broken Coast’s productive capacity at more than $5,200 per square foot, while comparable production capacity has been built from scratch for approximately $333 per square foot.

In other words, Aphria just paid 15.7 times more than what it could have paid if it decided to buy land and build a production facility from scratch.

This isn’t even the most ridiculous valuation metric one can ascribe to the deal; taking into consideration how much Aphria just paid for access to Broken Coast’s loyal customers, an easy $23,000 per patient was paid to Broken Coast for the honour of selling pot to each of its customers! While other firms, such as Canopy Growth Corp., have paid more on a per-patient basis for other acquisitions (as high as $26,000 per patient), seeing these numbers makes my eyes water, as I consider how much pot must be sold to these customers over time to make up the exorbitant acquisition cost taken on the backs of Aphria equity holders.

Bottom line

The argument that Aphria is doing the right thing in issuing shares ($220 million out of the $230 million will come from new equity) to acquire firms requires some funny logic in addition to the funny math. The logic goes:

  • A first-mover advantage is the only important thing cannabis companies should be shooting for right now.
  • The amount paid for an acquisition really doesn’t matter, as the share price will continue to climb, and marijuana producers can simply issue new shares at higher prices, diluting the current shareholder base by smaller amounts over time.
  • Productive capacity is somehow worth 15 times more today than it would be in one or two years from now.

The math and the logic make no sense whatsoever. When money is free and valuations continue to go to new ridiculous levels, fundamentals mean less and less. Who knows when the sector will implode, but I can tell you, I will never step foot in this sector in 2018 and beyond, until fundamentals show some semblance of reality.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

More on Investing

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Emerging Canadian AI Companies With Big Potential

These tech stocks are paving the way to an AI-filled future, but still offer enough growth ahead for a strong…

Read more »

Young Boy with Jet Pack Dreams of Flying
Tech Stocks

Is Constellation Software Stock a Buy, Sell, or Hold for 2025?

CSU stock has long been a strong option for high growth, high value stocks. But are there now too many…

Read more »

rising arrow with flames
Investing

2 Riskier Stocks With High Potential for Canadian Investors in November

Risky stocks such as Well Health Technologies have the potential to provide life-changing long-term returns.

Read more »

hand stacks coins
Dividend Stocks

3 Ultra-High-Yield Dividend Stocks You Can Buy and Hold for a Decade

These three high-yield dividend stocks still have some work to do, but each are in steady areas that are only…

Read more »

senior man and woman stretch their legs on yoga mats outside
Dividend Stocks

TFSA: 2 Canadian Stocks to Buy and Hold Forever

Here are 2 TFSA-worthy Canadian stocks. Which one is a good buy for your TFSA today?

Read more »

Canada day banner background design of flag
Investing

Got $500? 5 Top Canadian Stocks to Buy and Hold

These top Canadian stocks have solid fundamentals with potential to outperform the benchmark index by a wide margin.

Read more »

man touches brain to show a good idea
Energy Stocks

1 No-Brainer Energy Stock to Buy With $500 Right Now

Should you buy a cyclical energy stock at its decade-high? Probably not. But read this before you make a decision.

Read more »

Asset Management
Stocks for Beginners

TFSA: 4 Canadian Stocks to Buy and Hold Forever

Thinking about what to buy with the new TFSA contribution space in 2025? These four Canadian stocks are worth holding…

Read more »